Anthony J Perissinotti (Bernard L Marini)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 8

Top Topics

Acute Myeloid Leukemia

Ulcerative Colitis

Multiple Myeloma

Top Venues

Open forum infectious diseases

Leukemia & lymphoma

Infection control and hospital epidemiology

This page only lists publications with an associated author ORCID identifier.

Publications

Lauren T Shinn, Lydia L Benitez, Anthony J Perissinotti, Justin H Reid, Kaitlyn M Buhlinger, Hendrik van Deventer, Dylan Barth, Charlotte B Wagner, Kyle Zacholski, Ruchi Desai, Ashley Soule, Sarah E Stump, Taylor M Weis, Dale Bixby, Patrick Burke, Kristen Pettit, Anthony J Perissinotti
Multicenter evaluation of the addition of eltrombopag to immunosuppressive therapy for adults with severe aplastic anemia. International journal of hematology (2023)
Christy J Khouderchah, Lydia L Benitez, Anthony J Perissinotti, Martina Fraga, Kristen Pettit, Patrick W Burke, Dale L Bixby, Anthony J Perissinotti
Tumor lysis syndrome in patients with acute myeloid leukemia treated with venetoclax and hypomethylating agents with or without dose ramp-up. Leukemia & lymphoma (2023)
Timothée Olivier, Vinay Prasad, Anthony J Perissinotti
Hard-wired biases in trials: maintenance azacitidine in patients with acute myeloid leukemia and framework for future trials. Blood advances 6 (11) (2022)
Alina Varabyeva, Christabel Pui-See Lo, Adamo Brancaccio, Anthony J Perissinotti, Twisha Patel, Katie Sandison, Lydia L Benitez, Kristen Pettit, Patrick W Burke, Dale L Bixby, Anthony J Perissinotti
Impact of number of lumens in central-venous catheters on central-line bloodstream infection (CLABSI) and venous thromboembolism (VTE) risk in patients with acute leukemia. Infection control and hospital epidemiology (2021)
Morgan J Homan, Andrea Franson, Karthik Ravi, Holly Roberts, Manjunath P Pai, Cai Liu, Miao He, Aleksas Matvekas, Carl Koschmann, Anthony J Perissinotti
Panobinostat penetrates the blood-brain barrier and achieves effective brain concentrations in a murine model. Cancer chemotherapy and pharmacology 88 (3) (2021)
Anthony J Perissinotti, Anthony J Perissinotti, Dale L Bixby, Patrick W Burke, Kristen M Pettit, Lydia L Benitez
Mini-HCVD plus inotuzumab plus or minus blinatumomab: Hype or hope? Cancer 125 (21) (2019)
Heena P Patel, Anthony J Perissinotti, Twisha S Patel, Dale L Bixby, Vincent D Marshall, Bernard L Marini
Incidence and Risk Factors for Breakthrough Invasive Mold Infections in Acute Myeloid Leukemia Patients Receiving Remission Induction Chemotherapy. Open forum infectious diseases 6 (5) (2019)
Anthony J Perissinotti, Anthony J Perissinotti
Managing liver dysfunction in haematology patients: Switch antifungals, or use the tincture of time? Mycoses 62 (3) (2018)